GPCR (Structure Therapeutics Inc. American Depositary Shares) Stock Analysis - AI Report

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a publicly traded Healthcare sector company. As of May 20, 2026, GPCR trades at $36.92 with a market cap of $2.57B and a P/E ratio of -45.88. GPCR moved +2.84% today. Year to date, GPCR is -41.26%; over the trailing twelve months it is +49.45%. Its 52-week range spans $13.22 to $94.90. Analyst consensus is strong buy with an average price target of $110.69. Rallies surfaces GPCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on GPCR?

Rallies AI research for GPCR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

GPCR Key Metrics

Key financial metrics for GPCR
MetricValue
Price$36.92
Market Cap$2.57B
P/E Ratio-45.88
EPS$-0.80
Dividend Yield0.00%
52-Week High$94.90
52-Week Low$13.22
Volume1.20M
Avg Volume0
Revenue (TTM)$0
Net Income$-141.20M
Gross Margin0.00%

Latest GPCR News

GPCR Analyst Consensus

15 analysts cover GPCR: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.69.

Common questions about GPCR

What is the AI research view on GPCR?
Rallies AI research for GPCR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for GPCR?
Rallies AI research for GPCR combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is GPCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GPCR. It does not provide personalized investment advice.
GPCR

GPCR